Mederacke I - Search Results

1

Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D.

Anastasiou OE, Caruntu FA, Curescu MG, Yalcin K, Akarca US, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis GV, Keskin O, Port K, Radu M, Celen MK, Idilman R, Heidrich B, Mederacke I, von der Leyen H, Kahlhöfer J, von Karpowitz M, Hardtke S, Cornberg M, Yurdaydin C, Wedemeyer H. Anastasiou OE, et al. Among authors: mederacke i. Liver Int. 2024 Jan;44(1):139-147. doi: 10.1111/liv.15745. Epub 2023 Oct 3. Liver Int. 2024. PMID: 37787009

2

Spontaneous clearance of chronic hepatitis C after liver transplantation: are hepatitis C virus-specific T cell responses the clue?

Suneetha PV, Mederacke I, Heim A, Bastürk M, Cornberg M, Strassburg CP, Manns MP, Wedemeyer H. Suneetha PV, et al. Among authors: mederacke i. Liver Transpl. 2008 Aug;14(8):1225-7. doi: 10.1002/lt.21559. Liver Transpl. 2008. PMID: 18668659 Free article. No abstract available.

3

Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection.

Mederacke I, Wedemeyer H, Manns MP. Mederacke I, et al. Curr Opin Investig Drugs. 2009 Feb;10(2):181-9. Curr Opin Investig Drugs. 2009. PMID: 19197796 Review.

4

Nitazoxanide for the treatment of chronic hepatitis C new opportunities but new challenges?

Mederacke I, Wedemeyer H. Mederacke I, et al. Ann Hepatol. 2009 Apr-Jun;8(2):166-8. Ann Hepatol. 2009. PMID: 19502665 Free article. No abstract available.

5

Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection.

Mederacke I, Wursthorn K, Kirschner J, Rifai K, Manns MP, Wedemeyer H, Bahr MJ. Mederacke I, et al. Liver Int. 2009 Nov;29(10):1500-6. doi: 10.1111/j.1478-3231.2009.02100.x. Epub 2009 Sep 3. Liver Int. 2009. PMID: 19732330

6

[Interferon-alfa induced reactivation of sarcoidosis in a patient with chronic hepatitis C].

Mederacke I, Wursthorn K, Ho H, Manns MP, Wedemeyer H. Mederacke I, et al. Internist (Berl). 2010 Apr;51(4):522-7. doi: 10.1007/s00108-009-2543-3. Internist (Berl). 2010. PMID: 20186385 German.

7

Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics.

Mederacke I, Bremer B, Heidrich B, Kirschner J, Deterding K, Bock T, Wursthorn K, Manns MP, Wedemeyer H. Mederacke I, et al. J Clin Microbiol. 2010 Jun;48(6):2022-9. doi: 10.1128/JCM.00084-10. Epub 2010 Mar 29. J Clin Microbiol. 2010. PMID: 20351206 Free PMC article.

8

Peginterferon plus adefovir versus either drug alone for hepatitis delta.

Wedemeyer H, Yurdaydìn C, Dalekos GN, Erhardt A, Çakaloğlu Y, Değertekin H, Gürel S, Zeuzem S, Zachou K, Bozkaya H, Koch A, Bock T, Dienes HP, Manns MP; HIDIT Study Group. Wedemeyer H, et al. N Engl J Med. 2011 Jan 27;364(4):322-31. doi: 10.1056/NEJMoa0912696. N Engl J Med. 2011. PMID: 21268724 Free article. Clinical Trial.

9

Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum.

Wursthorn K, Jaroszewicz J, Zacher BJ, Darnedde M, Raupach R, Mederacke I, Cornberg M, Manns MP, Wedemeyer H. Wursthorn K, et al. Among authors: mederacke i. J Clin Virol. 2011 Apr;50(4):292-6. doi: 10.1016/j.jcv.2010.12.008. Epub 2011 Jan 26. J Clin Virol. 2011. PMID: 21273117

10

Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI).

Rifai K, Cornberg J, Mederacke I, Bahr MJ, Wedemeyer H, Malinski P, Bantel H, Boozari B, Potthoff A, Manns MP, Gebel M. Rifai K, et al. Among authors: mederacke i. Dig Liver Dis. 2011 Jun;43(6):491-7. doi: 10.1016/j.dld.2011.02.011. Epub 2011 Mar 24. Dig Liver Dis. 2011. PMID: 21439919 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page